Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects

Exendin-(9,39) is a competitive antagonist of glucagon-like peptide-1 (GLP-1) at its receptor. However, it is unclear if it has direct and unique effects of its own. We tested the hypothesis that exendin-(9,39) and GLP-1-(9,36)amide have direct effects on hormone secretion and β-cell function as wel...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Sathananthan, Matheni, Farrugia, Luca P., Miles, John M., Piccinini, Francesca, Dalla Man, Chiara, Zinsmeister, Alan R., Cobelli, Claudio, Rizza, Robert A., Vella, Adrian
פורמט: Artigo
שפה:Inglês
יצא לאור: American Diabetes Association 2013
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3717878/
https://ncbi.nlm.nih.gov/pubmed/23545708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db13-0140
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים